Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 2002

View Archived Issues

Emisphere reports on pipeline progress in 2001

Rho kinase as a target for drug discovery in Japan

Preclinical data support development of CS-758 for therapeutic use in fungal infections

Des-fluoroquinolone exerts potent activity against respiratory and genital Chlamydia

NO-flurbiprofen more effective and safer than flurbiprofen in accelerating tendon healing

Teicoplanin-loaded PLGA microspheres potentially useful in musculoskeletal infections

Novartis licenses AC-5216 from Dainippon

New antibiotic with selective activity against H. pylori

Preliminary phase IIIb results reported for transdermal oxybutynin in overactive bladder

ViroLogic technology used to evaluate Panacos HIV drug candidates

Phytomedics and Eisai collaborate to discover cancer therapeutics

Positive preclinical and clinical results for NCX-1015 in IBD and arthritis

Hollis-Eden signs CRADA for joint development of HE-2100 for radiation damage

Tranzyme and Gemin X enter neurological drug discovery collaboration

COLAL-PRED enters late-stage trials for ulcerative colitis

OP-1 Implant receives Canadian approval

NeoGenesis and Aventis collaborate on infectious disease drug discovery

F-12511 reduces hypercholesterolemia and progression of atherosclerotic lesions in rabbit model

Initiation of phase III trial of secretin in autism; further data analysis from phase II trial

Mutant heat-labile enterotoxin as a potent adjuvant for oral influenza vaccination

Results from the TIMI-8 trial confirm unique risk/benefit profile of bivalirudin

Taisho claims compounds that inhibit the production of 20-HETE

Compounds that enhance transcription factor AP-1 designed at Active Biotech

Cyclopentyl carboxamides with potential in female sexual dysfunction

Merck claims preparation of macrocyclic compounds for treatment of cancer, etc.

Abbott/Ligand jointly identify selective glucocorticoid modulators

Ortho-McNeil identifies nonpeptide vasopressin receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...